Apogee Therapeutics, Inc. (APGE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.58B |
| Enterprise Value | 4.46B |
| P/E Ratio | -30.61 |
| PEG Ratio | 1.66 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 7.35 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -28.46 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.21 |
| Return On Equity | -0.33 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.42M |
| EBITDA | -254.15M |
| Net Income | -255.84M |
| Diluted EPS | -4.22 |
Balance Sheet
| Total Cash | 1.06B |
| Total Cash/Share | 15.21 |
| Total Debt | 8.05M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 32.59 |
| Book Value Per Share | 18.03 |
Price History
| 52-Week Change | 220.56 |
| 52-Week High | 133 |
| 52-Week Low | 34.34 |
| Moving Average 50 Days | 84.76 |
| Moving Average 200 Days | 69.38 |
Statistics
| Average Volume | 974,516 |
| Shares Outstanding | 61.9M |
| % Held by Institutions | 130.27 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
